AU4829793A - Quinazoline derivatives - Google Patents

Quinazoline derivatives

Info

Publication number
AU4829793A
AU4829793A AU48297/93A AU4829793A AU4829793A AU 4829793 A AU4829793 A AU 4829793A AU 48297/93 A AU48297/93 A AU 48297/93A AU 4829793 A AU4829793 A AU 4829793A AU 4829793 A AU4829793 A AU 4829793A
Authority
AU
Australia
Prior art keywords
quinazoline derivatives
quinazoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48297/93A
Inventor
Andrew John Barker
Francis Thomas Boyle
Laurent Francois Andre Hennequin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Syngenta Ltd
Original Assignee
Zeneca Ltd
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd, British Technology Group Ltd filed Critical Zeneca Ltd
Publication of AU4829793A publication Critical patent/AU4829793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65128Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU48297/93A 1992-09-30 1993-09-28 Quinazoline derivatives Abandoned AU4829793A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9220571 1992-09-30
GB929220571A GB9220571D0 (en) 1992-09-30 1992-09-30 Quinazoline derivatives
PCT/GB1993/002015 WO1994007869A1 (en) 1992-09-30 1993-09-28 Quinazoline derivatives

Publications (1)

Publication Number Publication Date
AU4829793A true AU4829793A (en) 1994-04-26

Family

ID=10722718

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48297/93A Abandoned AU4829793A (en) 1992-09-30 1993-09-28 Quinazoline derivatives

Country Status (5)

Country Link
AU (1) AU4829793A (en)
GB (2) GB9220571D0 (en)
IL (1) IL107028A0 (en)
WO (1) WO1994007869A1 (en)
ZA (1) ZA936768B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320113D0 (en) * 1993-09-29 1993-11-17 Zeneca Ltd Tricyclic derivatives
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
US5753664A (en) * 1995-03-16 1998-05-19 Takeda Chemical Industries, Ltd. Heterocyclic compounds, their production and use
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
DK0981343T3 (en) 1997-05-14 2006-01-30 Atherogenics Inc Probucol monoesters for the treatment of cardiovascular and inflammatory disease
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
US6753428B2 (en) 2001-11-20 2004-06-22 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
CA2914168C (en) 2006-03-28 2018-05-08 Atir Holding S.A. Pyrido[1,2-a]pyrimidin-4-one derivatives and their use in the treatment of sexual disorders
US8252840B2 (en) 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
EP3581567A1 (en) 2011-04-10 2019-12-18 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
WO2021198191A1 (en) 2020-03-30 2021-10-07 Enyo Pharma Quinazolinone derivatives and uses thereof for treating a cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
AU640016B2 (en) * 1990-05-30 1993-08-12 Imperial Chemical Industries Plc Hydroquinazoline derivatives

Also Published As

Publication number Publication date
ZA936768B (en) 1994-03-30
GB9320077D0 (en) 1993-11-17
IL107028A0 (en) 1993-12-28
GB2271111A (en) 1994-04-06
WO1994007869A1 (en) 1994-04-14
GB9220571D0 (en) 1992-11-11

Similar Documents

Publication Publication Date Title
AU4156293A (en) Thiazolylvinylphenyl derivatives
AU5040696A (en) Quinazoline derivatives
AU5343396A (en) Quinazoline derivatives
AU5343296A (en) Quinazoline derivatives
AU5343096A (en) Quinazoline derivatives
AU2874789A (en) Quinazoline derivatives
AU4166393A (en) Auto-reclosers
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3388893A (en) Pyrimidine derivatives
AU4177593A (en) Benzophenonehydrazones
AU3042892A (en) Rockbolt
AU5184293A (en) Phthalazinone derivatives
AU4829793A (en) Quinazoline derivatives
AU3406793A (en) 2-oxoquinoline derivatives
AU4156393A (en) Heterocyclyltriazolinones
AU685768B2 (en) Benzazepinone derivatives
AU664253B2 (en) Photo-deviometer
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU3461693A (en) Saddle-cloth
AU3697893A (en) Propenoyl-imidazole derivatives
AU4164793A (en) Heterocyclyltriazolinones
AU4632493A (en) Weathershed
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls